Semaglutide Research Overview
- Popular Name
- GLP-1 Receptor Agonist
- Category
- Weight Loss & Metabolism
- Evidence Tier
- Approved Drug
- Class
- GLP-1 receptor agonist; fatty-acid conjugated 31-amino-acid peptide analog of human GLP-1
- Primary Target
- GLP-1 receptor (GLP1R); cAMP/PKA signaling; pancreatic beta-cell insulin secretion; hypothalamic appetite suppression; gastric emptying delay
- Half-Life
- ~1 week
- PubMed Citations
- 5,205
- Active Trials
- 399
Mechanism Of Action
It is a GLP-1 receptor agonist that slows gastric emptying and sends strong satiety signals to the hypothalamus, drastically reducing caloric intake and managing insulin release.
Studied For
Type 2 diabetes managementChronic weight management / obesityCardiovascular risk reductionHbA1c loweringAppetite suppressionBody weight reductionNon-alcoholic fatty liver disease (NAFLD/MASH)Kidney disease in diabetes (SELECT trial)
Sourcing Semaglutide In The Central Nebraska area
Pep Nation Lab supplies research-grade Semaglutide to verified researchers across Grand Island, NE, in Hall County and the wider Central Nebraska area. Every Semaglutide order ships nationwide with full batch COA documentation, strictly for in vitro laboratory use.
- Service Area
- Grand Island, NE (Central Nebraska)
- County
- Hall County, Nebraska
- ZIP Codes Served
- 68801, 68803
- Shipping
- Nationwide To All 50 States, Including Nebraska
- Compound
- Semaglutide (GLP-1 Receptor Agonist)
- Documentation
- Batch COA Included With Every Order
- Intended Use
- In Vitro Laboratory Research Only
Semaglutide In Grand Island - Common Questions
More Research Compounds In Grand Island
BPC-157 In Grand IslandTB-500 In Grand IslandTirzepatide In Grand IslandRetatrutide In Grand IslandAll Peptides In Grand Island›
Semaglutide In Nearby Cities

